nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—Mood swings—Dexamethasone—psoriatic arthritis	0.00442	0.00442	CcSEcCtD
Icosapent ethyl—Mood swings—Betamethasone—psoriatic arthritis	0.00442	0.00442	CcSEcCtD
Icosapent ethyl—Pancreatitis—Triamcinolone—psoriatic arthritis	0.00436	0.00436	CcSEcCtD
Icosapent ethyl—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.00435	0.00435	CcSEcCtD
Icosapent ethyl—Increased appetite—Prednisone—psoriatic arthritis	0.00432	0.00432	CcSEcCtD
Icosapent ethyl—Bronchitis—Triamcinolone—psoriatic arthritis	0.00427	0.00427	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00425	0.00425	CcSEcCtD
Icosapent ethyl—Neoplasm—Methotrexate—psoriatic arthritis	0.00423	0.00423	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00422	0.00422	CcSEcCtD
Icosapent ethyl—Affect lability—Prednisone—psoriatic arthritis	0.004	0.004	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Methotrexate—psoriatic arthritis	0.00398	0.00398	CcSEcCtD
Icosapent ethyl—Infestation—Methylprednisolone—psoriatic arthritis	0.00395	0.00395	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00395	0.00395	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.00391	0.00391	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.0039	0.0039	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Prednisone—psoriatic arthritis	0.00386	0.00386	CcSEcCtD
Icosapent ethyl—Mood swings—Prednisone—psoriatic arthritis	0.00385	0.00385	CcSEcCtD
Icosapent ethyl—Sweating—Methylprednisolone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Icosapent ethyl—Epistaxis—Triamcinolone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Icosapent ethyl—Rhinitis—Triamcinolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Icosapent ethyl—Rhinitis—Methylprednisolone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Icosapent ethyl—Abdominal distension—Prednisone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Icosapent ethyl—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Icosapent ethyl—Arrhythmia—Prednisolone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Icosapent ethyl—Pancreatitis—Prednisone—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Icosapent ethyl—Mood swings—Methotrexate—psoriatic arthritis	0.00322	0.00322	CcSEcCtD
Icosapent ethyl—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Icosapent ethyl—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Icosapent ethyl—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Prednisone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Icosapent ethyl—Malaise—Prednisolone—psoriatic arthritis	0.00304	0.00304	CcSEcCtD
Icosapent ethyl—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Icosapent ethyl—Vertigo—Prednisolone—psoriatic arthritis	0.00303	0.00303	CcSEcCtD
Icosapent ethyl—Syncope—Prednisolone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Icosapent ethyl—Back pain—Triamcinolone—psoriatic arthritis	0.003	0.003	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Icosapent ethyl—Asthma—Methotrexate—psoriatic arthritis	0.00293	0.00293	CcSEcCtD
Icosapent ethyl—Hypertension—Prednisolone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Icosapent ethyl—Arrhythmia—Betamethasone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Icosapent ethyl—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Icosapent ethyl—Pancreatitis—Methotrexate—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Icosapent ethyl—Alopecia—Betamethasone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Icosapent ethyl—Alopecia—Dexamethasone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Icosapent ethyl—Discomfort—Prednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Icosapent ethyl—Malaise—Triamcinolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Icosapent ethyl—Malaise—Methylprednisolone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Icosapent ethyl—Vertigo—Triamcinolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Icosapent ethyl—Syncope—Triamcinolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Icosapent ethyl—Vertigo—Methylprednisolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Icosapent ethyl—Syncope—Methylprednisolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Icosapent ethyl—Oedema—Prednisolone—psoriatic arthritis	0.00275	0.00275	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00272	0.00272	CcSEcCtD
Icosapent ethyl—Shock—Prednisolone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Icosapent ethyl—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Icosapent ethyl—Cough—Triamcinolone—psoriatic arthritis	0.0027	0.0027	CcSEcCtD
Icosapent ethyl—Tachycardia—Prednisolone—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Icosapent ethyl—Hypertension—Triamcinolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Icosapent ethyl—Hypertension—Methylprednisolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00266	0.00266	CcSEcCtD
Icosapent ethyl—Myalgia—Triamcinolone—psoriatic arthritis	0.00264	0.00264	CcSEcCtD
Icosapent ethyl—Pneumonia—Methotrexate—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Icosapent ethyl—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Icosapent ethyl—Myalgia—Methylprednisolone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Icosapent ethyl—Infestation NOS—Methotrexate—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Icosapent ethyl—Infestation—Methotrexate—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Icosapent ethyl—Discomfort—Triamcinolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Icosapent ethyl—Discomfort—Methylprednisolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Icosapent ethyl—Dry mouth—Triamcinolone—psoriatic arthritis	0.00258	0.00258	CcSEcCtD
Icosapent ethyl—Malaise—Dexamethasone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Icosapent ethyl—Malaise—Betamethasone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Icosapent ethyl—Oedema—Triamcinolone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Icosapent ethyl—Vertigo—Dexamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Icosapent ethyl—Vertigo—Betamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Icosapent ethyl—Syncope—Dexamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Icosapent ethyl—Syncope—Betamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Icosapent ethyl—Arrhythmia—Prednisone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Icosapent ethyl—Infection—Triamcinolone—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Icosapent ethyl—Sweating—Methotrexate—psoriatic arthritis	0.00251	0.00251	CcSEcCtD
Icosapent ethyl—Infection—Methylprednisolone—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Icosapent ethyl—Shock—Triamcinolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Icosapent ethyl—Insomnia—Prednisolone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Icosapent ethyl—Alopecia—Prednisone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Icosapent ethyl—Shock—Methylprednisolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Icosapent ethyl—Epistaxis—Methotrexate—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Icosapent ethyl—Tachycardia—Triamcinolone—psoriatic arthritis	0.00247	0.00247	CcSEcCtD
Icosapent ethyl—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Icosapent ethyl—Malnutrition—Prednisone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Icosapent ethyl—Hypertension—Dexamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Icosapent ethyl—Hypertension—Betamethasone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Icosapent ethyl—Myalgia—Dexamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Icosapent ethyl—Myalgia—Betamethasone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Icosapent ethyl—Discomfort—Betamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Icosapent ethyl—Discomfort—Dexamethasone—psoriatic arthritis	0.00236	0.00236	CcSEcCtD
Icosapent ethyl—Pain—Prednisolone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Icosapent ethyl—Pharyngitis—Methotrexate—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Icosapent ethyl—Oedema—Dexamethasone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Icosapent ethyl—Oedema—Betamethasone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Icosapent ethyl—Insomnia—Triamcinolone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Icosapent ethyl—Insomnia—Methylprednisolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Icosapent ethyl—Infection—Betamethasone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Icosapent ethyl—Infection—Dexamethasone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Icosapent ethyl—Shock—Dexamethasone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Icosapent ethyl—Shock—Betamethasone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Icosapent ethyl—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Icosapent ethyl—Tachycardia—Betamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Icosapent ethyl—Tachycardia—Dexamethasone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Icosapent ethyl—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Icosapent ethyl—Malaise—Prednisone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Icosapent ethyl—Vertigo—Prednisone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Icosapent ethyl—Syncope—Prednisone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Icosapent ethyl—Anorexia—Dexamethasone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Icosapent ethyl—Anorexia—Betamethasone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Icosapent ethyl—Pain—Triamcinolone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Prednisone—psoriatic arthritis	0.00215	0.00215	CcSEcCtD
Icosapent ethyl—Hypertension—Prednisone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Icosapent ethyl—Chills—Methotrexate—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Icosapent ethyl—Myalgia—Prednisone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Icosapent ethyl—Arthralgia—Prednisone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Icosapent ethyl—Alopecia—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Icosapent ethyl—Insomnia—Betamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Icosapent ethyl—Insomnia—Dexamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Icosapent ethyl—Discomfort—Prednisone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Icosapent ethyl—Malnutrition—Methotrexate—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Icosapent ethyl—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Icosapent ethyl—Dyspepsia—Betamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Icosapent ethyl—Dysgeusia—Methotrexate—psoriatic arthritis	0.002	0.002	CcSEcCtD
Icosapent ethyl—Body temperature increased—Triamcinolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Prednisone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Icosapent ethyl—Oedema—Prednisone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Icosapent ethyl—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Icosapent ethyl—Decreased appetite—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Icosapent ethyl—Infection—Prednisone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Icosapent ethyl—Back pain—Methotrexate—psoriatic arthritis	0.00198	0.00198	CcSEcCtD
Icosapent ethyl—Shock—Prednisone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Icosapent ethyl—Pain—Dexamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Icosapent ethyl—Pain—Betamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Icosapent ethyl—Tachycardia—Prednisone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Icosapent ethyl—Anorexia—Prednisone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Icosapent ethyl—Malaise—Methotrexate—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Icosapent ethyl—Vertigo—Methotrexate—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Icosapent ethyl—Dizziness—Prednisolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Icosapent ethyl—Asthenia—Triamcinolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Icosapent ethyl—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Icosapent ethyl—Body temperature increased—Betamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Icosapent ethyl—Asthenia—Methylprednisolone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Icosapent ethyl—Insomnia—Prednisone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Icosapent ethyl—Pruritus—Triamcinolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Icosapent ethyl—Cough—Methotrexate—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Icosapent ethyl—Pruritus—Methylprednisolone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Icosapent ethyl—Dyspepsia—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Icosapent ethyl—Arthralgia—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Icosapent ethyl—Myalgia—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Icosapent ethyl—Chest pain—Methotrexate—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Icosapent ethyl—Decreased appetite—Prednisone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Icosapent ethyl—Rash—Prednisolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Icosapent ethyl—Dermatitis—Prednisolone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Icosapent ethyl—Discomfort—Methotrexate—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Icosapent ethyl—Constipation—Prednisone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Icosapent ethyl—Dizziness—Triamcinolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Icosapent ethyl—Dizziness—Methylprednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Icosapent ethyl—Infection—Methotrexate—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Prednisone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Icosapent ethyl—Asthenia—Dexamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Icosapent ethyl—Asthenia—Betamethasone—psoriatic arthritis	0.00165	0.00165	CcSEcCtD
Icosapent ethyl—Pruritus—Betamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Icosapent ethyl—Pruritus—Dexamethasone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Icosapent ethyl—Vomiting—Triamcinolone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Icosapent ethyl—Vomiting—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Icosapent ethyl—Rash—Triamcinolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Icosapent ethyl—Dermatitis—Triamcinolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Icosapent ethyl—Anorexia—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Icosapent ethyl—Rash—Methylprednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Icosapent ethyl—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Icosapent ethyl—Body temperature increased—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Icosapent ethyl—Dizziness—Dexamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Icosapent ethyl—Dizziness—Betamethasone—psoriatic arthritis	0.00152	0.00152	CcSEcCtD
Icosapent ethyl—Insomnia—Methotrexate—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Icosapent ethyl—Dyspnoea—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Icosapent ethyl—Dyspepsia—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Icosapent ethyl—Vomiting—Dexamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Icosapent ethyl—Vomiting—Betamethasone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Icosapent ethyl—Decreased appetite—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Icosapent ethyl—Rash—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Icosapent ethyl—Rash—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Icosapent ethyl—Dermatitis—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Icosapent ethyl—Dermatitis—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Icosapent ethyl—Asthenia—Prednisone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Icosapent ethyl—Pain—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Icosapent ethyl—Pruritus—Prednisone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Icosapent ethyl—Dizziness—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Icosapent ethyl—Body temperature increased—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Icosapent ethyl—Vomiting—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Icosapent ethyl—Rash—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Icosapent ethyl—Dermatitis—Prednisone—psoriatic arthritis	0.00126	0.00126	CcSEcCtD
Icosapent ethyl—Asthenia—Methotrexate—psoriatic arthritis	0.0012	0.0012	CcSEcCtD
Icosapent ethyl—Pruritus—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Icosapent ethyl—Dizziness—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Icosapent ethyl—Vomiting—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Icosapent ethyl—Rash—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Icosapent ethyl—Dermatitis—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
